April 2011 if You Bought GEVA for $10 today you are getting $212
April 2015 if you bought GEVA for $100 Today you are getting $212
Mkt Cap = $2.9B ?????????????
Total Assets $8,951,400,000
Total Liabilities $4,108,400,000
Net Tangible Assets $4,680,300,000
Very low options used to bring it down...no worry amount of stock used from 13.60 to 13.20 USD is too much. This is going to bounce as Gold retained the 1220 mark and options cannot hold it low for long even if it expires tomorrow.
Probably GILD ask Hedge fund to hold ACHN low to get better buyout deal?
Somebody forgot the Math?
Gilead Sciences' hepatitis C success stems from its $11.2 billion acquisition of Pharmasset in 2012. That deal gave Gilead Sciences a deep bench of hepatitis C research that included Sovaldi and led to Harvoni, which is a combination of Sovaldi and Gilead Sciences' NS5A inhibitor ledipasvir. But The success of ACH-3102 suggests that it could be a better drug than ledipasvir!!!!!!!!!!
The Street On a potential takeover, the Adam Furestein said, "We continue to believe that if the Achillion combos are safe, efficacious, and competitive with the industry leading regimens from Gilead, as potentially proved by the Sparta doublet data and the Proxy triplet data in second half 2015
Short game is nearly over because ACHN to be $20+ if not $30